Advanced Filters
noise

diabetes-mellitus-type-1 Clinical Trials

A listing of diabetes-mellitus-type-1 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 371 clinical trials
A Adhiyat Najam

Type 1 Diabetes Virtual Self-management Education and Support

OVERVIEW: People living with type 1 diabetes (T1D) are expected to fit self-management and regular clinical consultations into busy lives. T1D self-management programs that offer frequent contact with care teams are most effective in helping patients achieve optimal glycemic control. However, this is difficult to deliver in the context of …

18 - 100 years of age Both Phase N/A
M Marianna Rachmiel, md

Efficacy of Hyperbaric Oxygen Therapy (HBOT) in New-onset Type-1 Diabetes Mellitus

Type 1 Diabetes Mellitus (T1DM) is caused by an autoimmune process that progressively destroys the pancreatic β-cells, and leads to dependence on multiple daily insulin subcutaneous injections according to glucose measurements and dietary restrictions, leading to short and long term complications. Current data demonstrate that even modest preservation of β-cell …

8 - 21 years of age Both Phase N/A
S Sanjay Bhadada, DM Endo

Comparison of Real-time CGMS With Intermittently-scanned CGMS in Adolescents and Adults With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus (T1DM) is characterized by absolute insulin deficiency. Despite multiple daily insulin injections, glycemic targets are usually not achieved in T1DM patients.Use of continuos glucose monitoring system (CGMS) is associated with improvement in glycemic control and reduction in glycemic variability in T1DM subjects. real-time CGMS (rt-CGMS) and …

15 - 40 years of age Both Phase N/A
L Laleh Vaziri

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

The goal of this clinical trial is to learn about the effect of the study drug (ZT-01) on low blood sugar (hypoglycemia) in adults with type 1 diabetes (T1D) who have been having low blood sugars ("hypos") at night. ZT-01 increases the amount of a hormone called glucagon during low …

18 - 75 years of age Both Phase 2
M Maka Hedrington, MD

Glucagon-like Peptide-1 in Type 1 Diabetes

The hypotheses to be tested in this application is: GLP-1 will acutely protect arterial endothelial function and reduce pro-atherothrombotic and pro-coagulant effects of repeated hypoglycemia in T1DM.

18 - 50 years of age Both Phase N/A

Butyrate Adjuvant Therapy for Type 1 Diabetes

The investigators are interested to evaluate the effect of BKR-017 (colon-targeted 500 mg butyrate tablets) as adjuvant therapy on metabolic control in type 1 diabetes (TID) subjects.

20 - 80 years of age Both Phase 1/2
T Teaniese L Davis, PhD, MPH

Type 1 Diabetes Education and Support Study

Diabetes distress has been identified as one of the largest contributors to the racial disparity in glycemic control that disproportionately burdens Black patients ages 18-30 years with type 1 diabetes (T1D). In order to combat this issue, this study assesses the feasibility of the culturally tailored intervention T1DES and evaluates …

18 - 30 years of age Both Phase N/A

Exercise Training and Endothelial Function in Type 1 Diabetes

Endothelial dysfunction and vasoreactivity disorders are early subclinical complications of type 1 diabetes (T1D). In a preventive setting, in T1D patients still free of complications, the research of non-pharmacological interventions to improve endothelial function appears fundamental. In this randomized controlled trial, the effects of exercise training on endothelial function will …

18 - 50 years of age Both Phase N/A

Resistance Exercise and Cognition in People With Type 1 Diabetes

The aim of the current study is to determine the effects of resistance exercise on performance of the Paced Auditory Serial Addition Test and the Colour Trails Test.

21 - 60 years of age Both Phase N/A

Remote Digital Care Effects in Adolescents With Type 1 Diabetes

Pilot study to evaluate effects of an experimental additional remote digital care (TELEDUC-DIAB) to adolescents with poorly controlled type 1 diabetes using digital monitoring platform and educative app

12 - 17 years of age Both Phase N/A

Rewrite in simple language using AI